1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Schering-Plough

Anonymous board for Schering-Plough.

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    9
    Views:
    3,081
  2. anonymous
    Replies:
    7
    Views:
    2,363
  3. anonymous
    Replies:
    4
    Views:
    1,499
  4. Anonymous
    Replies:
    8
    Views:
    6,601
  5. Anonymous
    Replies:
    9
    Views:
    3,381
  6. Anonymous
    Replies:
    15
    Views:
    8,125
  7. Anonymous
    Replies:
    255
    Views:
    55,613
  8. Anonymous
    Replies:
    23
    Views:
    9,183
  9. Anonymous
    Replies:
    8
    Views:
    5,169
  10. Anonymous
    Replies:
    5
    Views:
    3,569
  11. Anonymous
    Replies:
    36
    Views:
    16,511
  12. Anonymous
    Replies:
    2
    Views:
    3,008
  13. Anonymous
    Replies:
    10
    Views:
    4,814
  14. Anonymous
    Replies:
    17
    Views:
    7,281
  15. Anonymous
    Replies:
    4
    Views:
    3,321
  16. Anonymous
    Replies:
    11
    Views:
    7,928
  17. Anonymous
    Replies:
    3
    Views:
    3,286
  18. Anonymous
    Replies:
    8
    Views:
    4,788
  19. Anonymous
    Replies:
    15
    Views:
    7,900
  20. Anonymous
    Replies:
    17
    Views:
    9,017

Thread Display Options

Loading...